Genenta Science S.P.A. - ADR
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Genenta Science S.P.A. - ADR
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.
/ 
Frequently asked questions
To buy Genenta Science S.P.A. - ADR stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Genenta Science S.P.A. - ADR by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Genenta Science S.P.A. - ADR is GNTA:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Genenta Science S.P.A. - ADR has its primary listing on NASDAQ (Small cap). You can trade Genenta Science S.P.A. - ADR with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Genenta Science S.P.A. - ADR is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Genenta Science S.P.A. - ADR as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Genenta Science S.P.A. - ADR.